Search Results
Showing 10 from 12 results
Producing Quality Products That Improve Lives
At Teva we believe that everyone should have access to safe quality medicine that helps manage disease fights infection or simply improves overall health
Biosimilars are advancing more treatment options for patients
Cory Wohlbach is responsible for steering Teva s new biosimilar products through the regulatory approval process He explains what biosimilars are how they have the potential to reduce costs for patients and how patient safety is always a top priority
Generic Medicines and R D How Teva Produces the World s Biggest Medicine Cabinet
We explain why generic medicines are an essential part of modern healthcare and look at the research development processes and logistical challenges involved in creating them
Why Diversity in Clinical Trials is So Important
Clinical trials are essential for the development of medicines and it s increasingly recognised there is a growing need for diversity in these trials Teva investigates why and outlines how it is working to increase diverse representation in clinical trials
Generic Medicines and Regulation Producing the World s Biggest Medicine Cabinet Safely and Effectively
Most people know what generic medicines are products created to be the same as branded drugs whose patents have expired